Smiths Group PLC
1 November 2001
Smiths Group News Release
London, 1 November 2001
For immediate release
Smiths adds to Medical technologies with US acquisition
Smiths Group has acquired Bivona Medical Technologies, a leading US supplier
of silicone tubes used in anaesthesia and critical care. It has been acquired
from Saint-Gobain Performance Plastics Corporation for $35.6 million. Bivona
significantly extends Smiths Medical's core product range of single-use
disposable devices, adding new product and material technologies and
strengthening its position in the market for paediatric devices.
Commenting on the acquisition, chief executive Keith Butler-Wheelhouse said:
'Vital to the continued success of our Medical division is the regular
introduction of new products. We achieve this through a growing level of R & D
and also by acquiring innovative businesses such as Bivona. This company will
provide an excellent fit with our airway management business, enhancing our
core Medical activities by adding a well established range of high-margin
devices. This will provide an exciting new dimension to our global
operations.'
Bivona is a specialist supplier of silicone tracheostomy tubes for specific
applications in hospital, and long-term use outside the hospital by patients
who require a mechanical ventilator. Its other specialisation is endotracheal
tubes, reinforced with wire to meet special surgical/anatomical requirements.
These are used to maintain an airway through the mouth to the lungs during
anaesthesia.
Annual sales of Bivona products are $21 million and the company has a strong
record of annual growth. With less than 20 per cent of sales currently outside
the US, Bivona is expected to realise considerable advantage from Smiths
Medical's world-wide distribution network, particularly in Europe and Japan.
Bivona's silicone products complement the extensive Portex range of single-use
devices manufactured in the US and UK and marketed world-wide. Portex tubes,
made of PVC, are lower cost, more rigid devices, typically used for short
periods. For some applications, particularly in babies and infants, and for
long-term use, a softer material such as silicone is preferred.
Bivona employs 260 people at Gary, Indiana, near Chicago. The consideration of
$35.6 million was paid in cash and completion of the acquisition was
simultaneous with the signing of the purchase agreement.
Smiths Medical has annual sales of £453m and profits of £93m. In addition to
airway management products, its key activities include pain management,
temperature management, needle protection, hospital and ambulatory infusion
systems, critical care monitoring, vascular access, and women's healthcare.
Smiths Group is a global business with market-leading positions in advanced
aerospace systems; mechanical and polymer seals; medical devices and critical
care equipment; and interconnect products. Further information can be found on
the company's website: www.smiths-group.com.
-ends-
Press enquiries to:
Richard Bayliss
Tel: 020 8457 8306
richard.bayliss@smiths-group.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.